These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11929349)

  • 21. The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden.
    Lindgren P; Stenestrand U; Malmberg K; Jönsson B
    Clin Ther; 2005 Jan; 27(1):100-10. PubMed ID: 15763611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clopidogrel: a pharmacoeconomic review of its use in patients with non-ST elevation acute coronary syndromes.
    Lyseng-Williamson KA; Plosker GL
    Pharmacoeconomics; 2006; 24(7):709-26. PubMed ID: 16802846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reducing the risk: heart disease, stroke and aspirin.
    Elwood PC
    J Med Assoc Thai; 2001 Aug; 84(8):1164-74. PubMed ID: 11758854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clopidogrel versus aspirin for secondary prophylaxis of vascular events: a cost-effectiveness analysis.
    Schleinitz MD; Weiss JP; Owens DK
    Am J Med; 2004 Jun; 116(12):797-806. PubMed ID: 15178495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of triflusal on arteriosclerosis progression assessed with high-resolution arterial ultrasound.
    Cesarone MR; Laurora G; DeSanctis MT; Incandela L; Fugazza L; Girardello R; Poli A; Peracino L; Ambrosoli L; Belcaro G
    Angiology; 1999 Jun; 50(6):455-63. PubMed ID: 10378821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes in Spain.
    Gómez-Gerique JA; Casciano R; Stern L; Rejas J
    Eur J Health Econ; 2004 Oct; 5(3):278-84. PubMed ID: 15714350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is treatment with aspirin combined with dipyridamole really more cost-effective than aspirin alone?
    Heidebrink JL
    Arch Intern Med; 2001 May; 161(9):1236. PubMed ID: 11343453
    [No Abstract]   [Full Text] [Related]  

  • 28. Cost-effectiveness of clopidogrel in STEMI patients in the Netherlands: a model based on the CLARITY trial.
    Thurston SJ; Heeg B; de Charro F; van Hout B
    Curr Med Res Opin; 2010 Mar; 26(3):641-51. PubMed ID: 20070142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspirin desensitization in patients with coronary artery disease: Cost savings.
    Cubero JL; Simó Sánchez B; Millán P; Colás C
    Med Intensiva; 2017 Oct; 41(7):446-447. PubMed ID: 28196671
    [No Abstract]   [Full Text] [Related]  

  • 30. Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.
    Jamieson DG; Parekh A; Ezekowitz MD
    J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):153-61. PubMed ID: 16211203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Durlaza--a 24-hour extended-release aspirin.
    Med Lett Drugs Ther; 2016 Jan; 58(1486):7. PubMed ID: 26761340
    [No Abstract]   [Full Text] [Related]  

  • 32. A cost-utility analysis of clopidogrel in patients with ST elevation acute coronary syndromes in the UK.
    Karnon J; Holmes MW; Williams R; Bakhai A; Brennan A
    Int J Cardiol; 2010 Apr; 140(3):315-22. PubMed ID: 19106007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
    Second Chinese Cardiac Study (CCS-2) Collaborative Group
    J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of a Cardiovascular Polypill in the Treatment of Secondary Prevention Patients in Spain: A Cost-effectiveness Study.
    Barrios V; Kaskens L; Castellano JM; Cosin-Sales J; Ruiz JE; Zsolt I; Fuster V; Gracia A
    Rev Esp Cardiol (Engl Ed); 2017 Jan; 70(1):42-49. PubMed ID: 27474481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Acute coronary syndrome. The second platelet inhibitor is self-paid].
    MMW Fortschr Med; 2003 Jun; 145(24):52. PubMed ID: 12866304
    [No Abstract]   [Full Text] [Related]  

  • 36. Triflusal versus acetylsalicylic acid: a double-blind study for the prophylaxis of deep vein thrombosis after hip surgery.
    Putz P; Buyse H; Delvaux D; Kutnowski M; Demulder A; Dumont N; Lavenne E; Claes R; Rosillon D
    Acta Chir Belg; 1991; 91(6):269-76. PubMed ID: 1781229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triflusal in the treatment of patients with chronic peripheral arteriopathy: multicentre double-blind clinical study vs placebo.
    Auteri A; Angaroni A; Borgatti E; Catalano M; De Vizzi GB; Forconi S; Fossati L; Girardello R; Ambrosoli L; Poli A
    Int J Clin Pharmacol Res; 1995; 15(2):57-63. PubMed ID: 8593974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial.
    Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox KM; Hennerici MG; Mattle HP; Rothwell PM; de Cordoüe A; Fratacci MD;
    Lancet; 2011 Jun; 377(9782):2013-22. PubMed ID: 21616527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of triflusal on oxidative stress, prostaglandin production and nitric oxide pathway in a model of anoxia-reoxygenation in rat brain slices.
    González-Correa JA; Arrebola MM; Ureña IM; Guerrero A; Muñoz-Marín J; Ruiz-Villafranca D; Sánchez De La Cuesta F; De La Cruz JP
    Brain Res; 2004 Jun; 1011(2):148-55. PubMed ID: 15157801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness analysis of short-term clopidogrel therapy for ST elevation myocardial infarction.
    Gibler KB; Huskamp HA; Sabatine MS; Murphy SA; Cohen DJ; Cannon CP
    Crit Pathw Cardiol; 2010 Mar; 9(1):14-8. PubMed ID: 20215905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.